These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

686 related items for PubMed ID: 28031050

  • 21. Prognostic value of gross tumor regression and plasma Epstein Barr Virus DNA levels at the end of intensity-modulated radiation therapy in patients with nasopharyngeal carcinoma.
    Liang SB, Zhang N, Chen DM, Yang XL, Chen BH, Zhao H, Lu RL, Chen Y, Fu LW.
    Radiother Oncol; 2019 Mar; 132():223-229. PubMed ID: 30366725
    [Abstract] [Full Text] [Related]

  • 22. Is replacement of the supraclavicular fossa with the lower level classification based on magnetic resonance imaging beneficial in nasopharyngeal carcinoma?
    Yue D, Xu YF, Zhang F, Lin L, Mao YP, Li WF, Chen L, Sun Y, Liu LZ, Lin AH, Li L, Ma J.
    Radiother Oncol; 2014 Oct; 113(1):108-14. PubMed ID: 25245557
    [Abstract] [Full Text] [Related]

  • 23. Prognostic value of MRI-derived masticator space involvement in IMRT-treated nasopharyngeal carcinoma patients.
    Xiao Y, Pan J, Chen Y, Lin S, Chen Y, Zong J, Fang Y, Guo Q, Chen B, Tang L.
    Radiat Oncol; 2015 Sep 25; 10():204. PubMed ID: 26407897
    [Abstract] [Full Text] [Related]

  • 24. Clinical Outcome and Prognostic Factors of Intensity-Modulated Radiotherapy for T4 Stage Nasopharyngeal Carcinoma.
    Luo Y, Gao Y, Yang G, Lang J.
    Biomed Res Int; 2016 Sep 25; 2016():4398498. PubMed ID: 27195286
    [Abstract] [Full Text] [Related]

  • 25. Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: A 10-year experience with a large cohort and long follow-up.
    Zhang MX, Li J, Shen GP, Zou X, Xu JJ, Jiang R, You R, Hua YJ, Sun Y, Ma J, Hong MH, Chen MY.
    Eur J Cancer; 2015 Nov 25; 51(17):2587-95. PubMed ID: 26318726
    [Abstract] [Full Text] [Related]

  • 26. Re-evaluation of the prognostic significance of retropharyngeal node metastasis in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy.
    Chen B, Zhan Z, Pan J, Xiao Y, Tang L, Guo Q, Xu Y, Zong J, Zhang R, Xu H, Lin S.
    Asia Pac J Clin Oncol; 2022 Apr 25; 18(2):e173-e181. PubMed ID: 34541812
    [Abstract] [Full Text] [Related]

  • 27. Failure patterns and prognostic factors for cervical node-negative nasopharyngeal carcinoma in the intensity-modulated radiotherapy era.
    Wu Z, Wang L, Xie DH, Lv SW, Su Y, Shi YR.
    Asia Pac J Clin Oncol; 2021 Aug 25; 17(4):330-337. PubMed ID: 33079493
    [Abstract] [Full Text] [Related]

  • 28. The efficacy and toxicity of individualized intensity-modulated radiotherapy based on the tumor extension patterns of nasopharyngeal carcinoma.
    Lin L, Yao JJ, Zhou GQ, Guo R, Zhang F, Zhang Y, Xu L, Zhang LL, Lin AH, Ma J, Sun Y.
    Oncotarget; 2016 Apr 12; 7(15):20680-90. PubMed ID: 26980744
    [Abstract] [Full Text] [Related]

  • 29. Analysis of rare periparotid recurrence after parotid gland-sparing intensity-modulated radiotherapy for nasopharyngeal carcinoma.
    Xu Y, Zhang M, Yue Q, Zong J, Lin J, Sun R, Qiu S, Lin S, Pan J.
    Cancer Radiother; 2016 Jul 12; 20(5):377-83. PubMed ID: 27372558
    [Abstract] [Full Text] [Related]

  • 30. Long-term Therapeutic Outcome and Prognostic Factors of Patients with Nasopharyngeal Carcinoma Receiving Intensity-modulated Radiotherapy: An Analysis of 608 Patients from Low-endemic Regions of China.
    Huang J, Yang ZY, Wu B, Ding Q, Qin Y, Zhang ZJ, Yin ZY, Liang ZW, Han J, Wang Y, Peng ZJ, Peng G, Li Q, Wu G, Yang KY.
    Curr Med Sci; 2021 Aug 12; 41(4):737-745. PubMed ID: 34403099
    [Abstract] [Full Text] [Related]

  • 31. Nasopharyngeal carcinoma treated with intensity-modulated radiotherapy: clinical outcomes and patterns of failure among subsets of 8th AJCC stage IVa.
    Huang CL, Guo R, Li JY, Xu C, Mao YP, Tian L, Lin AH, Sun Y, Ma J, Tang LL.
    Eur Radiol; 2020 Feb 12; 30(2):816-822. PubMed ID: 31650266
    [Abstract] [Full Text] [Related]

  • 32. Clinical treatment considerations in the intensity-modulated radiotherapy era for patients with N0-category nasopharyngeal carcinoma and enlarged neck lymph nodes.
    Peng H, Chen L, Guo R, Zhang Y, Li WF, Mao YP, Sun Y, Zhang F, Liu LZ, Tian L, Ma J.
    Chin J Cancer; 2017 Mar 24; 36(1):32. PubMed ID: 28340596
    [Abstract] [Full Text] [Related]

  • 33. A retrospective study comparing the outcomes and toxicities of intensity-modulated radiotherapy versus two-dimensional conventional radiotherapy for the treatment of children and adolescent nasopharyngeal carcinoma.
    Qiu WZ, Peng XS, Xia HQ, Huang PY, Guo X, Cao KJ.
    J Cancer Res Clin Oncol; 2017 Aug 24; 143(8):1563-1572. PubMed ID: 28342002
    [Abstract] [Full Text] [Related]

  • 34. Clinical Analysis of Recurrence Patterns in Patients With Nasopharyngeal Carcinoma Treated With Intensity-Modulated Radiotherapy.
    Wang L, Guo Y, Xu J, Chen Z, Jiang X, Zhang L, Huang S, He X, Zhang Y.
    Ann Otol Rhinol Laryngol; 2017 Dec 24; 126(12):789-797. PubMed ID: 29025277
    [Abstract] [Full Text] [Related]

  • 35. Distribution pattern and prognosis of metastatic lymph nodes in cervical posterior to level V in nasopharyngeal carcinoma patients.
    Jiang C, Gao H, Zhang L, Li H, Zhang T, Ma J, Liu B.
    BMC Cancer; 2020 Jul 17; 20(1):667. PubMed ID: 32680466
    [Abstract] [Full Text] [Related]

  • 36. Prognostic value of grading masticator space involvement in nasopharyngeal carcinoma according to MR imaging findings.
    Zhang GY, Huang Y, Cai XY, Chen XP, Xu T, Wu J, Wei WH, Liu LZ, Huang ZL, Zhou MM, Xia ST, Wang YJ.
    Radiology; 2014 Oct 17; 273(1):136-43. PubMed ID: 24844470
    [Abstract] [Full Text] [Related]

  • 37. Clinical features and survival outcomes between ascending and descending types of nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: A big-data intelligence platform-based analysis.
    Yao JJ, Qi ZY, Liu ZG, Jiang GM, Xu XW, Chen SY, Zhu FT, Zhang WJ, Lawrence WR, Ma J, Zhou GQ, Sun Y.
    Radiother Oncol; 2019 Aug 17; 137():137-144. PubMed ID: 31102988
    [Abstract] [Full Text] [Related]

  • 38. Magnetic Resonance Imaging-Detected Intracranial Extension in the T4 Classification Nasopharyngeal Carcinoma with Intensity-Modulated Radiotherapy.
    Cao C, Luo J, Gao L, Yi J, Huang X, Li S, Xiao J, Zhang Z, Xu G.
    Cancer Res Treat; 2017 Apr 17; 49(2):518-525. PubMed ID: 27554478
    [Abstract] [Full Text] [Related]

  • 39. Comparison of the treatment outcomes of intensity-modulated radiotherapy and two-dimensional conventional radiotherapy in nasopharyngeal carcinoma patients with parapharyngeal space extension.
    Tang LL, Chen L, Mao YP, Li WF, Sun Y, Liu LZ, Lin AH, Mai HQ, Shao JY, Li L, Ma J.
    Radiother Oncol; 2015 Aug 17; 116(2):167-73. PubMed ID: 26316395
    [Abstract] [Full Text] [Related]

  • 40. The N staging system in nasopharyngeal carcinoma with radiation therapy oncology group guidelines for lymph node levels based on magnetic resonance imaging.
    Mao YP, Liang SB, Liu LZ, Chen Y, Sun Y, Tang LL, Tian L, Lin AH, Liu MZ, Li L, Ma J.
    Clin Cancer Res; 2008 Nov 15; 14(22):7497-503. PubMed ID: 19010867
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.